Supernus Pharmaceuticals Target Price

Explore Supernus Pharmaceuticals's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$47.87

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-02-25	Craig-Hallum	$65	35.8% upside
2025-12-19	Stifel NicolausAnnabel Samimy	$55	14.9% upside
2025-10-08	Piper Sandler	$65	35.8% upside
2025-09-30	Cantor Fitzgerald	$63	31.6% upside
2025-08-29	Piper Sandler	$40	16.4% downside
2025-07-29	Cantor Fitzgerald	$42	12.3% downside
2024-09-11	Piper SandlerDavid Amsellem	$36	24.8% downside
2024-05-24	Piper SandlerDavid Amsellem	$41	14.4% downside
2024-04-08	JefferiesIrene Buhalo	$40	16.4% downside
2024-04-08	Stifel NicolausAnnabel Samimy	$38	20.6% downside

Supernus Pharmaceuticals (SUPN) FAQ

Stockcircle tracks target price for Supernus Pharmaceuticals (SUPN), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Supernus Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main SUPN overview so you can move from this figure to the surrounding analysis quickly.